Literature DB >> 18781211

Intrapouch injections of botulinum toxin type A for the management of unit contractions of a continent urinary diversion.

Arash Gharajeh1, Stephen S Steele, D Robert Siemens.   

Abstract

A 43-year-old woman presented with abdominal pain associated with incontinence from her Indiana pouch continent urinary diversion due to significant unit contractions. The patient's symptoms were refractory to conservative management, including oral and intrapouch antimuscarinic agents. Prior to surgical reconstruction, a trial of intrapouch injections of botulinum toxin type A (BT-A) significantly improved both the abdominal pain and the incontinence. The benefit lasted about 6 months and was subsequently repeated for recurrent symptoms. To our knowledge, this is the first reported case of the management of complications of a continent urinary diversion with BT-A injections.

Entities:  

Year:  2008        PMID: 18781211      PMCID: PMC2532546          DOI: 10.5489/cuaj.843

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  15 in total

1.  Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.

Authors:  D M Schmid; P Sauermann; M Werner; B Schuessler; N Blick; M Muentener; R T Strebel; D Perucchini; D Scheiner; G Schaer; H John; A Reitz; D Hauri; B Schurch
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

2.  Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity.

Authors:  Antonella Giannantoni; Savino M Di Stasi; Vincenza Nardicchi; Alessandro Zucchi; Lara Macchioni; Vittorio Bini; Gianfrancesco Goracci; Massimo Porena
Journal:  J Urol       Date:  2006-06       Impact factor: 7.450

3.  Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.

Authors:  Gilles Karsenty; André Reitz; Gertraud Lindemann; Sönke Boy; Brigitte Schurch
Journal:  Urology       Date:  2006-12-04       Impact factor: 2.649

4.  Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.

Authors:  Christopher P Smith; Jun Nishiguchi; Margie O'Leary; Naoki Yoshimura; Michael B Chancellor
Journal:  Urology       Date:  2005-01       Impact factor: 2.649

5.  Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.

Authors:  B Schurch; M Stöhrer; G Kramer; D M Schmid; G Gaul; D Hauri
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

6.  Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder.

Authors:  David E Rapp; Katherine W Turk; Gregory T Bales; Sean P Cook
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

7.  Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.

Authors:  H Schulte-Baukloh; J Schobert; T Stolze; B Stürzebecher; C Weiss; H H Knispel
Journal:  Neurourol Urodyn       Date:  2006       Impact factor: 2.696

8.  Nonsurgical treatment of chronic anal fissure: nitroglycerin and dilatation versus nifedipine and botulinum toxin.

Authors:  Philippe Tranqui; Daniel C Trottier; Charles Victor; Joel B Freeman
Journal:  Can J Surg       Date:  2006-02       Impact factor: 2.089

9.  Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre.

Authors:  Vinay Kalsi; Roshni B Popat; Apostolos Apostolidis; Rajesh Kavia; Isaac A O Odeyemi; Helen A Dakin; Juliet Warner; Soheir Elneil; Clare J Fowler; Prokar Dasgupta
Journal:  Eur Urol       Date:  2005-12-22       Impact factor: 20.096

10.  Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.

Authors:  A Apostolidis; R Popat; Y Yiangou; D Cockayne; A P D W Ford; J B Davis; P Dasgupta; C J Fowler; P Anand
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.